1-6 of 6
James H Anderson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

John A. Galloway, MD, FACP: A Pharmaceutical Physician and Leader in Diabetes Therapy

Free
James H. Anderson
Journal: Diabetes Care
Diabetes Care 2018;41(12):2448–2452
https://doi.org/10.2337/dci18-0042
Published: 12 November 2018
View articletitled, John A. Galloway, MD, FACP: A Pharmaceutical Physician and Leader in Diabetes Therapy
Open the PDF for John A. Galloway, MD, FACP: A Pharmaceutical Physician and Leader in Diabetes Therapy in another window
Journal Articles

Effect of Long-Term Exposure to Insulin Lispro on the Induction of Antibody Response in Patients With Type 1 or Type 2 Diabetes

Free
S. Edwin Fineberg, MD, Jie Huang, PHD, Rocco Brunelle, MS, K. S. Gulliya, PHD, James H. Anderson, Jr, MD
Journal: Diabetes Care
Diabetes Care 2003;26(1):89–96
https://doi.org/10.2337/diacare.26.1.89
Published: 01 January 2003
View articletitled, Effect of Long-Term Exposure to Insulin Lispro on the Induction of Antibody Response in Patients With Type 1 or Type 2 Diabetes
Open the PDF for Effect of Long-Term Exposure to Insulin Lispro on the Induction of Antibody Response in Patients With Type 1 or Type 2 Diabetes in another window
Journal Articles

Meta-Analysis of the Effect of Insulin Lispro on Severe Hypoglycemia in Patients With Type 1 Diabetes

Free
Rocco L Brunelle, MS, Julie Llewelyn, MB, James H Anderson, Jr, Edwin A M Gale, MB, Veikko A Koivisto, MD
Journal: Diabetes Care
Diabetes Care 1998;21(10):1726–1731
https://doi.org/10.2337/diacare.21.10.1726
Published: 01 October 1998
View articletitled, Meta-Analysis of the Effect of Insulin Lispro on Severe Hypoglycemia in Patients With Type 1 Diabetes
Open the PDF for Meta-Analysis of the Effect of Insulin Lispro on Severe Hypoglycemia in Patients With Type 1 Diabetes in another window
Journal Articles

Reduced Frequency of Severe Hypoglycemia and Coma in Well-Controlled IDDM Patients Treated With Insulin Lispro

Free
Frits Holleman, MD, Henry Schmitt, MD, Raoul Rottiers, MD, Alan Rees, MD, FRCP, Sharon Symanowski, PHD, James H Anderson, MD, The Benelux-UK Insulin Lispro Study Group
Journal: Diabetes Care
Diabetes Care 1997;20(12):1827–1832
https://doi.org/10.2337/diacare.20.12.1827
Published: 01 December 1997
View articletitled, Reduced Frequency of Severe Hypoglycemia and Coma in Well-Controlled IDDM Patients Treated With Insulin Lispro
Open the PDF for Reduced Frequency of Severe Hypoglycemia and Coma in Well-Controlled IDDM Patients Treated With Insulin Lispro in another window
Journal Articles

Mixing Insulin Lispro and Ultralente Insulin

Free
Edward J Bastyr, III, MD, John H Holcombe, MD, James H Anderson, MD, John N Clore, MD
Journal: Diabetes Care
Diabetes Care 1997;20(6):1047–1048
https://doi.org/10.2337/diacare.20.6.1047
Published: 01 June 1997
View articletitled, Mixing Insulin Lispro and Ultralente Insulin
Open the PDF for Mixing Insulin Lispro and Ultralente Insulin in another window
Journal Articles

Biosynthetic Human Proinsulin: Review of Chemistry, in Vitro and in Vivo Receptor Binding, Animal and Human Pharmacology Studies, and Clinical Trial Experience

Free
John A Galloway, MD, Susan A Hooper, PHD, C Thomas Spradlin, PHD, Daniel C Howey, MD, Bruce H Frank, PHD, Ronald R Bowsher, PHD, James H Anderson, MD
Journal: Diabetes Care
Diabetes Care 1992;15(5):666–692
https://doi.org/10.2337/diacare.15.5.666
Published: 01 May 1992
View articletitled, Biosynthetic Human Proinsulin: Review of Chemistry, in Vitro and in Vivo Receptor Binding, Animal and Human Pharmacology Studies, and Clinical Trial Experience
Open the PDF for Biosynthetic Human Proinsulin: Review of Chemistry, in Vitro and in Vivo Receptor Binding, Animal and Human Pharmacology Studies, and Clinical Trial Experience in another window